If an animal could speak, would we listen?
It is hard to see how researchers can succeed without deception, though this trickery is bound to raise hackles. PHOTO: PETER MARSHALL
Mention Dr Dolittle, and it is impossible not to hum the film's Oscar-winning ditty written by Leslie Bricusse and sung by Rex Harrison: 'Think what it would mean if I could talk to the animals, just imagine it/Chatting to a chimp in chimpanzee/Imagine talking to a tiger, chatting to a cheetah/What a neat achievement that would be.'
The famed, fictional naturalist has now inspired a lucrative science prize aimed at cracking the challenge of inter-species communication. Last week, an inaugural US$100,000 (S$129,000) went to a US team studying dolphin whistles.
Join ST's Telegram channel and get the latest breaking news delivered to you.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
2 hours ago
- Straits Times
Used in Covid-19 shots, mRNA may help rid the body of HIV
The new study describes the use of mRNA as a tool to flush HIV out of its hiding places. PHOTO: UNSPLASH Used in Covid-19 shots, mRNA may help rid the body of HIV NEW YORK - The technology that powered Covid-19 vaccines may also lead scientists to a cure for HIV. Using mRNA, Australian researchers said they were able to trick the virus to come out of hiding, a crucial step in ridding the body of it entirely. The research, published last week in Nature Communications, is still preliminary and so far has been shown to be successful only in a lab. But it suggests that mRNA has potential far beyond its use in vaccines as a means to deliver therapies against stubborn adversaries. Short for messenger RNA, mRNA is a set of instructions for a gene. In the case of Covid-19 vaccines, the instructions were for a piece of the coronavirus. In the new study, they are for molecules key to targeting HIV. Dr Sharon Lewin, director of the Doherty Institute at the University of Melbourne, who led the study, called mRNA a 'miraculous' tool 'to deliver things that you want into places that were not possible before.' Vaccines deploying mRNA instruct the body to produce a fragment of the virus, which then sets off the body's immune response. In the United States, the shots were initially hailed for turning back the pandemic, then viewed by some with suspicion and fear. Some officials, including Health Secretary Robert F. Kennedy Jr, have falsely said that they are highly dangerous and even deadly. Last week, the Department of Health and Human Services sought to limit the vaccine's availability to pregnant women, children and healthy younger adults. The administration also cancelled a nearly US$600 million (S$773.72 million) contract with the drugmaker Moderna to develop an mRNA shot for humans against bird flu. 'The fear right now is not rational,' Dr Lewin said, adding that 'mRNA vaccines have been given to millions of people around the world, so we have a very good understanding of their risks.' The new study describes the use of mRNA as a tool to flush HIV out of its hiding places. Other uses could involve providing proteins missing from those with certain diseases or correcting genetic errors. Dr Frauke Muecksch, a virologist at Heidelberg University in Germany who was not involved in the work, called mRNA a 'promising, absolutely powerful technology.' Although most people may have only heard of mRNA's use in science during the pandemic, scientists have been working with it for more than 20 years, she said. 'I think it's not just therapeutically very powerful, but also for basic science, for research, it opens up a lot of avenues,' she added. Potent antiretroviral drugs can now control HIV, suppressing it to undetectable levels. Still, minute amounts of the virus lie dormant in so-called reservoirs, waiting for an opportunity to resurge. A cure for HIV would involve ferreting out all of this virus and destroying it, a strategy that has been called 'shock and kill.' A significant hurdle is that the virus lies dormant in a particular type of immune cell, called a resting CD4 cell. Because these cells are inactive, they tend to be unresponsive to drugs. The few drugs scientists have previously used to rouse the virus in these cells were not specific to HIV and had unwanted side effects. 'It's fair to say the field's been a little bit stuck,' said Dr Brad Jones, a viral immunologist at Weill Cornell Medicine who was not involved in the latest research. In 2022, Dr Jones and his colleagues found that the immune boost from the mRNA vaccines awakened latent HIV in people living with the virus. (Other research has shown that mRNA vaccines also activated dormant viruses including Epstein Barr.) 'You get just a little bit of a gentle nudge with some of these vaccines, and it's enough to coax some of these latent viruses out so they can be killed,' Dr Jones said. Dr Lewin and her colleagues had for years experimented with other ways to activate HIV, but had no luck in resting cells. Seeing the success of the Covid-19 vaccines, which used lipid nanoparticles – tiny spheres of fat – containing mRNA, her team tested similar particles. They used the particles to deliver two different sets of molecules: Tat, which is adept at switching HIV on, and CRISPR, a tool that can 'edit' genes. The researchers showed that in resting immune cells from people living with HIV, the approach coaxed the virus out of dormancy. 'It's very, very hard to deal with these cells, so I think this really targeting the right population of cells is what makes this paper special,' Dr Muecksch said. It's unclear whether the new approach can successfully awaken all of the dormant HIV in the body, and what side effects it might produce. Dr Lewin said that 'mRNA will almost certainly have some adverse effects, as every drug does, but we will investigate that systematically, as we do for any new drug.' In this case, she said, side effects may be more acceptable to people living with HIV than having to take medications for the rest of their lives. The researchers plan to test the method in HIV-infected animals next, before moving into clinical trials. NYTIMES Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
5 hours ago
- Straits Times
Harvard gets other universities' backing in Trump funding fight
Harvard sued in April, claiming the government freeze violates the university's First Amendment guarantee of free speech. PHOTO: BLOOMBERG BOSTON, Massachusetts – A group of 18 leading US research universities, including Princeton, MIT, Caltech and Johns Hopkins, asked a federal judge for permission to file legal arguments in support of Harvard University in its high-stakes showdown with the Trump administration over more than US$2 billion (S$2.58 billion) in frozen grant money. The institutions have all received millions of dollars from the federal government for research that has 'advanced scientific knowledge, safeguarded national security, strengthened the American economy, and saved countless lives,' they said in a court filing on June 6 in Harvard's lawsuit. Harvard sued in April, claiming the government freeze violates the university's First Amendment guarantee of free speech and federal law governing administrative rulemaking. The fight is part of a broad-based effort by President Donald Trump to force sweeping changes at Harvard and other elite US universities. The government has also frozen or is reviewing federal funding to Princeton, Cornell, Northwestern and Columbia universities, among others. Harvard claims in its suit, filed in Boston federal court, that the Trump administration illegally suspended its funding in retaliation for its refusal to bow to 'unconstitutional demands' to overhaul governance, discipline and hiring policies, as well as diversity programmes. The president claims Harvard, the nation's oldest and richest university, has failed to combat anti-Semitism on campus and encourage viewpoint diversity. 'The cuts will disrupt ongoing research, ruin experiments and datasets, destroy the careers of aspiring scientists, and deter long-term investments at universities across the country,' the universities said in a request to file amicus curiae or 'friend of the court' arguments supporting Harvard's case against the government. The request to support Harvard also comes from Boston University, Brown University, Colorado State University, Dartmouth College, Michigan State University, Oregon State University, Rice University, Rutgers University, Tufts University, University of Maryland at College Park, University of Oregon, University of Pennsylvania, University of Pittsburgh and Yale University. A group of states led by Massachusetts, where Harvard is located, also asked to file arguments in support of the university on June 6. BLOOMBERG Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
a day ago
- Straits Times
‘Cracking the wall' between AI and medicine
Professor Wong Tien Yin is embarking on a project to build an AI hospital for China's top-rated Tsinghua University. ST PHOTO: NG SOR LUAN Nowhere has the excitement over how artificial intelligence (AI) will transform our lives been more potent than in the area of medicine, where it's been held to such lofty standards that people expect it will some day – hopefully soon – wipe out epidemics, extend human lifespan and maybe even cure cancer. The idea that AI will improve healthcare is not up for dispute. Real-life applications have already yielded positive results in more accurate and faster diagnostics, and streamlined operations in medical settings. Join ST's Telegram channel and get the latest breaking news delivered to you.
